Navigation Links
Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives

Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back... -- BEIJING, Aug. 24 /PRNewswire-Asia/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals Click to view news release full screen  

Novel Stem Cell Therapy From Cellonis Biotechnologies Can Help Children With Diabetes Get Back Their Normal Lives


BEIJING, Aug. 24 /PRNewswire-Asia/ -- Cellonis Biotechnologies, a Beijing and HK-based medical research and application company, has recorded some remarkable results in the treatment of a twelve-year-old boy with diabetes using their stem cell therapy in a Beijing partner hospital. He has completely regained his normal life, enjoying sports and school activities just like every other person his age, and has been free from injections and drugs for more than half a year.

"Our whole family is delighted with this outcome," his mother commented in a Cellonis interview. "He is now no different from any other child at his school. There is no sign of diabetes anymore. He previously coughed a lot in spring and winter, but after the therapy we haven't seen him coughing at all. We are very pleased."

The boy's doctor during the treatment, Dr. Shi, is similarly satisfied. "The efficacy of our patient's treatment surprised me a lot," she commented. "He hasn't taken insulin injections for eight months, and so does not need to worry about his blood glucose during PE.

"Also, diabetes can stunt a child's growth, with diabetic children being smaller and weaker than other children, but he has grown more than 10cm during this last half year. This is excellent news."

Preventing Dangerous Complications From Diabetes

Diabetes can be especially damaging to children, as it also affects them socially. They have to take care when playing, maintain a healthy diet, and take unpleasant insulin injections daily. Children with diabetes have a much greater risk of complications such as those affecting the kidneys and eyes.

Conventional treatments cannot prevent long-term complications and often have harmful side effects. The Cellonis stem cell therapy is suitable for all ages, with no side effects reported.

"Stem cell treatment is a new hope for diabetes sufferers," Dr. Shi continued. "It can replace dysfunctional pancreatic cells, getting to the root of the disease. Stem cell treatment, both for diabetes and for many other diseases, represents a new age for medicine."

Cellonis Biotechnologies focuses on R&D and the clinical application of personalized stem cell therapies and immunotherapies for patients with diseases including cancer, diabetes and central nervous system disorders.

Urs. J. Lienert COO-International Cellonis Phone: +86-150-1054-7487 Email: Web:

SOURCE Cellonis Biotechnologies Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
2. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
3. UC Riverside researcher develops novel method to grow human embryonic stem cells
4. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
5. CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases
6. Spherics, Inc. Announces Sale of Novel Proprietary Bioadhesive Polymers and Oral Drug Delivery System
7. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
8. Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds
9. Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure
10. Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture
11. Trius Awarded $28 Million Contract to Develop Novel Antibiotics
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... The New ... age children in the areas of Science, Technology, Engineering and Mathematics. The skill ... economy, and the program aims to increase the number of students who pursue ...
(Date:10/12/2015)... and BRUSSELS , Oct. 12, 2015 ... UCB) today presented additional findings from an exploratory sub-study of ... findings were presented today in an oral plenary session at ... Annual Meeting in Seattle . ... --> The small exploratory sub-study data showed that, at ...
(Date:10/12/2015)... Group, Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and the Dental sectors of healthcare, announced today the ... Company has been dismissed by the court.  ... "As we suspected, this case was brought by an ...
(Date:10/12/2015)... Minn. , Oct. 12, 2015  Rebiotix ... Administration (FDA) has designated its lead Microbiota Restoration ... the treatment of recurrent Clostridium difficile ... (GI) infection that causes 29,000 deaths in the ... stage biotechnology company that was founded to revolutionize ...
Breaking Biology Technology:
(Date:10/6/2015)... Calif. , Oct. 6, 2015  Maverix ... today announced enhancements to its software portfolio with ... analysis kit for differential expression in eukaryotes. The ... which is a cloud-based genomic analysis solution that ... scientific discovery from next-generation sequencing efforts. ...
(Date:10/2/2015)... , Oct. 02 2015 ... of the "Enforcing the Law Using Biometrics" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Enforcing the Law Using Biometrics" ...
(Date:9/30/2015)...  With nearly 300,000 Americans living with spinal cord ... to reach 12,500 annually, the role of Independent Living ... Independent Living (SCRS-IL) is increasingly important. SCRS-IL is ... opening doors to independence for individuals with SCIs ... assistive technology services and education. "In serving ...
Breaking Biology News(10 mins):